BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38128117)

  • 1. Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
    Yuk JS; Kim T; Cho H; Gwak G
    Eur J Endocrinol; 2024 Jan; 190(1):1-11. PubMed ID: 38128117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal hormone therapy increases the risk of gallstones: Health Insurance Database in South Korea (HISK)-based cohort study.
    Yuk JS; Park JY
    PLoS One; 2023; 18(12):e0294356. PubMed ID: 38048308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea-based retrospective cohort study.
    Yuk JS; Kim JM
    Menopause; 2023 May; 30(5):497-505. PubMed ID: 36917757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal hormone therapy and risk of dementia: health insurance database in South Korea-based retrospective cohort study.
    Yuk JS; Lee JS; Park JH
    Front Aging Neurosci; 2023; 15():1213481. PubMed ID: 37744387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial cancer risk with menopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
    Yuk JS
    Int J Gynaecol Obstet; 2023 Aug; 162(2):502-513. PubMed ID: 36964935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of menopausal hormone therapy on the risk of ovarian cancer: Health Insurance Database in South Korea-based cohort study.
    Yuk JS; Kim M
    Menopause; 2023 May; 30(5):490-496. PubMed ID: 37022299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Menopausal Hormone Therapy and Oral Cancer: A Cohort Study Based on the Health Insurance Database in South Korea.
    Yuk JS; Kim BY
    J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is breast cancer risk the same for all progestogens?
    Stute P
    Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
    DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
    J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?
    Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
    J Clin Oncol; 2009 Nov; 27(31):5138-43. PubMed ID: 19752341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal hormone therapy and the risk of cataracts in postmenopausal women in South Korea.
    Yuk JS; Park JY; Sim HE; Hwang JH
    Ophthalmic Physiol Opt; 2023 Mar; 43(2):254-262. PubMed ID: 36609995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Menopausal Hormone Therapy and Risk for Parkinson's Disease.
    Yuk JS; Jeong SH
    J Parkinsons Dis; 2023; 13(8):1357-1367. PubMed ID: 37980684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopause, hysterectomy, menopausal hormone therapy and cause-specific mortality: cohort study of UK Biobank participants.
    Xu Z; Chung HF; Dobson AJ; Wilson LF; Hickey M; Mishra GD
    Hum Reprod; 2022 Aug; 37(9):2175-2185. PubMed ID: 35690930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
    Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
    J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context.
    Chlebowski RT; Aragaki AK
    Menopause; 2023 Apr; 30(4):454-461. PubMed ID: 36727752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between menopausal hormone therapy and breast cancer: A nationwide population-based cohort study.
    Yuk JS
    Int J Gynaecol Obstet; 2024 Mar; ():. PubMed ID: 38469634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France.
    Cordina-Duverger E; Truong T; Anger A; Sanchez M; Arveux P; Kerbrat P; Guénel P
    PLoS One; 2013; 8(11):e78016. PubMed ID: 24223752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal hormone therapy and risk of incident hypertension: role of the route of estrogen administration and progestogens in the E3N cohort.
    Madika AL; MacDonald CJ; Fournier A; Mounier-Vehier C; Béraud G; Boutron-Ruault MC
    Menopause; 2021 Sep; 28(11):1204-1208. PubMed ID: 34581294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.